Vertex Pharmaceuticals: director Alan M Garber received 29.272 shares

What happened

• Alan M Garber, a director, received 29.272 deferred stock units (derivative award) on Oct 15, 2026, at a price of $512.44 per share, for a total reported value of $15,000.

Key details

• Transaction date and price: Oct 15, 2026; $512.44 per share.
• Transaction type: Award/Grant (derivative deferred stock units).
• Shares owned after the transaction: not reported in the provided filing.
• Footnote F1: each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Dr. Garber's service on our board of directors, (ii) a change of control of our company and (iii) Dr. Garber's disability or death.
• Filing date: Oct 19, 2026; filed within the 2 business days typically required after an Oct 15, 2026 transaction.

Why it may matter

• This was a grant of deferred stock units (a derivative award), not an immediate open-market purchase or sale.
• A filing does not show why the insider traded or why the company acted.